Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pancreas ductal adenocarcinoma (PDAC) has a poor prognosis. Identifying risk factors through preoperative staging and neoadjuvant treatment can improve patient selection for surgery and reduce early recurrence.
Area Of Science
- Oncology
- Surgical Oncology
- Gastroenterology
Background
- Pancreas ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a dismal 5-year survival rate of 12%.
- Despite curative-intent resection, many patients experience early recurrence within two years, leading to cancer-related death.
- Optimizing patient selection for surgery is crucial to improve outcomes for PDAC patients.
Purpose Of The Study
- To review evidence supporting multidisciplinary and multimodality preoperative staging for PDAC.
- To evaluate comprehensive neoadjuvant treatment strategies for PDAC.
- To define optimal patient selection criteria for curative-intent surgical resection of PDAC.
Main Methods
- Review of existing evidence on preoperative staging, neoadjuvant therapies, and patient selection for PDAC.
- Analysis of data from a standardized approach at the Mayo Clinic.
- Extrapolation of findings to inform future research directions.
Main Results
- Thorough preoperative staging can identify risk factors for early recurrence after PDAC resection.
- Multidisciplinary and multimodality staging approaches are essential for comprehensive patient evaluation.
- Neoadjuvant treatment strategies may improve resectability and patient outcomes.
- Standardized approaches can refine patient selection for surgical intervention.
Conclusions
- Identifying preoperative risk factors is key to selecting appropriate candidates for PDAC resection.
- A multidisciplinary, multimodality approach to staging and neoadjuvant therapy is recommended.
- Optimized patient selection can potentially reduce early recurrence rates and improve survival in PDAC.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
